SCHEMBL9730116

SCHEMBL9730116

Cc1nnn(-c2ccc(F)cc2)c1CCC(O)CC(O)CC(=O)O

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 6/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9731213 0.90 HMGCR (0.42) HMGCR
SCHEMBL9730322 0.87 HMGCR (0.50) HMGCR
SCHEMBL9730728 0.86 HMGCR (0.45) HMGCR
SCHEMBL9730867 0.79 HMGCR (0.40) HMGCR
SCHEMBL9729971 0.76 HMGCR (0.42) HMGCR
SCHEMBL9730326 0.76 HMGCR (0.51) HMGCR
SCHEMBL9730319 0.76 HMGCR (0.51) HMGCR
SCHEMBL9729993 0.76 HMGCR (0.54) HMGCR
SCHEMBL9730011 0.74 HMGCR (0.56) HMGCR
SCHEMBL3809636 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5081136-A 1,2,3-TRIAZOLE COMPOUNDS ACTIVE AS INHIBITORS OF THE ENZYME HMG-COA REDUCTASE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ZAMBON GROUP S.P.A. (IT) 1992-01-14 US disclosed
EP-0433842-A2 1,2,3-Triazole derivatives active as inhibitors of the enzyme HMG-COA reductase and pharmaceutical compositions containing them ZAMBON GROUP S.p.A. (IT) 1991-06-26 EP disclosed